 BOCA RATON, Fla.--BUSINESS WIRE--TherapeuticsMD, Inc. NASDAQ: TXMD, an innovative, leading womens healthcare company, and Theramex, a dedicated womens health company, announced that BIJUVE has received approval from the Medicines and Healthcare products Regulatory Agency MHRA for use in the United Kingdom and, from the Federal Agency for Medicines and Health Products FAMHP for use in Belgium under BIJUVA. A decentralized procedure DCP for the regulatory approval of BIJUVA in se 